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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYUnderstanding the mechanisms responsible for nephrogenic stem cell preservation and commitment is fundamental to harnessing the
potential of the metanephric mesenchyme (MM) for nephron regeneration. Accordingly, we established a culture model that preferen-
tially expands the MM SIX2+ progenitor pool using leukemia inhibitory factor (LIF), a Rho kinase inhibitor (ROCKi), and extracellular
matrix. Passaged MM cells express the key stem cell regulators Six2 and Pax2 and remain competent to respond to WNT4 induction
and form mature tubular epithelia and glomeruli. Mechanistically, LIF activates STAT, which binds to a Stat consensus sequence in the
Six2 proximal promoter and sustains SIX2 levels. ROCKi, on the other hand, attenuates the LIF-induced differentiation activity of
JNK. Concomitantly, the combination of LIF/ROCKi upregulates Slug expression and activates YAP, which maintains SIX2, PAX2, and
SALL1. Using this novel model, our study underscores the pivotal roles of SIX2 and YAP in MM stem cell stability.INTRODUCTION
Although considerable progress has been made in under-
standing the cues that direct self-renewal and differentia-
tionof pluripotent stemcells (Buehr et al., 2008), the factors
and pathways capable of perpetuating any multipotent
tissue-specific progenitor in the absence of immortalizing
genetic modifications remain largely undefined. During
development, reciprocal interactions between the ureteric
bud (UB) and the surrounding metanephric mesenchyme
(MM) direct the formation of the metanephros. The MM
promotes the branching morphogenesis of the UB to
generate the collecting duct network. In turn, the UB in-
duces condensation and mesenchymal-epithelial transi-
tion (MET) in the MM to initiate nephron formation at
each bud tip. Condensed cells of the MM cap the tips of
the branching UB in the cortical nephrogenic zone of the
metanephros and provide a self-renewing population of
SIX2+ progenitors, which supply the precursors for neph-
ronic epithelia (Kobayashi et al., 2008). Ablation of Six2 re-
sults in the premature commitment of these progenitors
and a depletion of the progenitor pool. Therefore, SIX2 is
a major determinant in the maintenance and self-renewal
of the nephronic precursor. The aggregate SIX2-expressing
population is further regulated by the transcriptional co-
activator and Hippo pathway component Yes-associated
protein (YAP) and is growth-limited by signals emanating
from the encapsulating cortical stroma (Das et al., 2013).
The loss of stromal signals promotes the expansion of
undifferentiated SIX2+ stem cells, stimulates the nuclearStem CelllocalizationofYAP, and inhibits the formationofnephronic
structures. Conversely, Yap ablation causes renal hypopla-
sia, characterized by a measureable deficit in progenitor
self-renewal and fewer nephrons. These findings led us to
hypothesize that constitutive activation of SIX2 and YAP
is sufficient to sustain this tissue-specific stem cell.
During development, extrinsic signals in a progenitor’s
microenvironment provide cues for self-renewal and lineage
commitment. Although several growth factors, including
fibroblast growth factors (FGFs) 2 (Perantoni et al., 1995), 8
(Perantoni et al., 2005), 9, and 20 (Barak et al., 2012) and
epidermal growth factor (EGF)/transforming growth factor
a (TGF-a) (Rogers et al., 1992), support the survival of MM
cells and facilitate the limited expansion of this population
in culture, they have proven to be insufficient for long-
term propagation of progenitors with stem-like properties
andnephronicpotential. Inthis study,weoptimize theniche
for rat progenitors using growth factors, extracellularmatrix,
and Rho kinase inhibitor, which, in combination, sustain
SIX2andYAPnuclear expression.Moreover,wedemonstrate
that these factors contribute to the preferential propagation
and partial stabilization of MM progenitors with the preser-
vation of stemcellmarkers and a capacity for differentiation.
RESULTS
The Extracellular Matrix Helps Stabilize MM
Progenitors
Primary cultures of MMwere generated from developmen-
tally comparable embryonic day (E) 13.5 rat or E11.5mouseReports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Authors 435
Figure 1. LIF and Y27632 Support the
Retention of Progenitor Marker Expres-
sion in Cultured MMs
(A) Schematic of the MM cell culture
method. Isolated rat or mouse MMs were
explanted on culture dishes in serum-free
medium.
(B and C) Expression levels of the progenitor
markers Six2 and Pax2 (B) and the differ-
entiation marker E-cadherin (C) in cells
grown in control (FT) medium or LIF or
Y27632 for 10 days on laminin. Uncultured
rMMs at E13.5 were used for comparison.
(D) RT-PCR expression profiles for cells
grown in FT or FTLY medium on fibronectin.
Uncultured rMMs served as controls. noRT,
no reverse transcriptase control.metanephric rudiments (Figure 1A). MMs were dissected
from trypsin-treated metanephroi and cultured as intact
masses (10/60-mm dish) for up to 10 days using 50 ng/ml
FGF2 and 10 ng/ml TGF-a (referred to as FT medium) to
promote the survival and growth of cells (Perantoni et al.,
1995; Plisov et al., 2001). To establish whether these condi-
tions support progenitor self-renewal, primary cultures of
rat MMs (rMMs) in FT medium were analyzed for markers
associated with cap mesenchyme or MM progenitor
maintenance, i.e., Six2, Pax2 (Kobayashi et al., 2008; Torres
et al., 1995), and Cited1 (Plisov et al., 2005), by qPCR (Fig-
ure 1B; Figure S1A). Compared with uncultured rMM con-
trols, cells grown on regular tissue culture dishes showed
substantial loss of expression of each of these markers,
indicating that FT conditions were inadequate for long-
term SIX2+ progenitor propagation. To stabilize stem cell
marker expression, culture conditions were modified436 Stem Cell Reports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Authorsthrough the addition of matrix coat-
ings, growth factors, and small-mole-
cule inhibitors.
The extracellular matrix associated
with nephron formation is restruc-
tured radically at MET in vivo. During
this morphogenesis, laminin replaces
fibronectin in newly formed epithelia
(Ekblom et al., 1980). To determine
whether the matrix itself helps stabi-
lize the progenitors, primary explants
(2/well) in FT medium were seeded
onto matrix-coated, 24-well culture
dishes and examined after 10 days
for expression of progenitor markers
and cell proliferation. Compared
with dishes bearing no matrix, cellson fibronectin or laminin expressed elevated levels of the
progenitor markers Six2 and Cited1 (Figure S1A). Matrigel
stimulated a 10-fold increase in the epithelial marker
Lim1, suggesting that cells were differentiating on this
coating, and its use was discontinued. Cell proliferation
was also evaluated, but cell numbers were not significantly
affected by changes in matrix (Figure S1B). Given the abil-
ity of matrix coatings to elevate the expression of stem
markers, fibronectin- or laminin-coated dishes were em-
ployed in all subsequent studies.
LIF and the Rho Kinase Inhibitor Y27632 Support the
Self-Renewal of MM Progenitors
Leukemia inhibitory factor (LIF) induces MET in primary
rMM cells, generating tubules and glomerulus-like struc-
tures (Barasch et al., 1999; Plisov et al., 2001). It is expressed
both by the UB and MM, whereas LIF receptors are found
on cap progenitors and newly formed nephronic epithelia
(Plisov et al., 2001). Because LIF treatment also greatly
expanded the size of rMM explants, we postulated a role
for LIF in rMM self-renewal. Moreover, the Rho kinase in-
hibitor Y27632 or a dominant-negative RhoA construct
also increased the size of cultured mouse MM (mMM) col-
onies (Osafune et al., 2006). Accordingly, we investigated
the ability of these two factors to regulate the growth of
rMMs in culture. For this, ten primary rMM explants were
seeded onto fibronectin-coated wells of 6-well dishes and
treated for 10 days, with medium replacement every
2–3 days. Individually both LIF (1 ng/ml) and Y27632
(10 mM) nearly doubled cell counts relative to controls in
FT medium, and simultaneous treatment yielded numbers
nearly four times those of controls, demonstrating that
both factors contribute independently to the proliferation
of rMMs (Figure S1C). Furthermore, 5 ng/ml LIF yielded no
significant increase over the 1 ng/ml treatment, suggesting
that the lower level is optimal for growth. Based on final
cell counts, the population expansion was achieved with
more than eight cell doublings during the 10-day period.
To determine whether LIF stimulation or Rho kinase in-
hibition stabilized the expression of stem cell markers, cells
were evaluated for Six2 and Pax2 expression. Cultured
rMMs were treated with LIF (0.5–10 ng/ml) or Y27632
(5.0–20 mM) in FT medium to maximize marker expression
and minimize any concomitant stimulation of expression
of the differentiation marker E-cadherin. For these studies,
primary explants of MM (3/well in a 24-well laminin-
coated plate) were cultured for 10 days and then analyzed
by qPCR. Overall, the highest concentrations of LIF and
Y27632 supported the most robust expression of Six2
and Pax2 (Figure 1B). Levels of Six2 expression were three
times greater than those observed in uncultured rMMs,
whereas Pax2 levels approached those of uncultured
MMs. However, E-cadherin expression was also elevated
greatly (>15-fold), suggesting that these higher levels
shifted the balance between stemness and commitment
to MET (Figure 1C). In combination with FT factors, lower
levels of LIF (1 ng/ml) and Y27632 (10 mM) provided the
best balance, supporting expression of both stem cell
markers with only a 2-fold induction of E-cadherin. This
will be referred to hereafter as FTLY medium. When the
study was expanded to evaluate the expression of several
markers of intermediate mesoderm, rMMs, condensed
mesenchyme (e.g., Cited1, Pax2/8, Osr1, Sall1, Six1/2, and
Wt1), or stroma (Foxd1, Pbx1, andMeis1/2) by semiquanti-
tative RT-PCR, the expression levels of FTLY-treated cells
were generally equal to or greater than those of the progen-
itors (rMM lane) fromwhich they were derived (Figure 1D).
Again, FT-treated cultures failed to maintain Pax2 expres-
sion. Bmp7 has previously been linked to proliferation of
these progenitors (Blank et al., 2009), and our conditionsStem Cellalso stabilized its expression, suggesting that stimulation
of growth may be mediated in part by this factor. Interest-
ingly, the stromal progenitor marker Foxd1 was greatly
reduced in FTLY medium, whereas the stromal markers
Pbx1 and Meis 1/2 increased, suggesting that FTLY either
does not support self-renewal of stromal progenitors or
that it facilitates their conversion to SIX2+ progenitors,
which is less likely given the increased Pbx1/Meis1/2 levels
with FT and FTLY media.
Progenitor status was further documented by immuno-
fluorescence (IF) staining for the stem cell markers SIX2,
PAX2, and SALL1, all of which localize to the nucleus dur-
ing development (Figure 2A; Figure S2). Cells were grown
for 10 days in FTLY medium and then dissociated and re-
plated in FT or FTLY medium for 3 additional days on lam-
inin-coated, 4-well chamber slides (50,000 cells/well).
When probed for SIX2, rMM cells showed frequent nuclear
staining in FTLY-treated cultures but only limited staining
in FT-treated control cultures. Similarly, nuclear staining
for PAX2 was more prominent in FTLY-treated cultures.
SALL1, on the other hand, was detected in the nuclei of
both control (FT-treated) and FTLY-treated cultures (Fig-
ure S2). These observations are consistent with our results
from gene expression studies and suggest an association
between FTLY treatment and the increased incidence of
SIX2 nuclear expression.
To quantify the effects of FTLY treatment on the SIX2+
progenitor population in mixed MM cultures, cells were
analyzed for nuclear expression of SIX2 or the stromal
marker PBX1 (Boivin et al., 2015) by IF. Freshly isolated
rMMs contained 30% SIX2+ and 70% PBX1+ cells (Fig-
ures 2B and 2C). For unpassaged cells, 3 explants/well
were dispersed by pipetting and seeded in 4-well, fibro-
nectin-coated chamber slides. With FTLY treatment for
7 days, the SIX2+ population increased to nearly 50%,
whereas FT treatment caused a 50% decline in the SIX2+
population. Therefore, FTLY not only sustained the SIX2+
progenitors but also preferentially expanded this popula-
tion. To assess the population dynamics in subsequent
passages, cells were dissociated with trypsin and evaluated
as monolayer cultures. Confluent cells were trypsinized
and seeded into chamber-slide wells (50,000 cells/well)
with fixation the following day. The SIX2+ population
peaked at over 65% by passage 2. By passage 3, however,
the FTLY-expanded SIX2+ population declined and was
largely replaced by SIX2/PBX1/CADHERIN6(CDH6)+
epithelium-like clusters (Figure S3). CDH6 is primarily
expressed in newly formed nephronic epithelium (Cho
et al., 1998), suggesting that the SIX2+ cells had initiated
MET. These clusters did not stain for E-CADHERIN
(ECDH, data not shown), consistent with progression
only to primitive epithelium. Regardless, a significant per-
centage of cells (8%) remained SIX2+ in FTLY-treatedReports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Authors 437
Figure 2. FTLY Preferentially Expands the
SIX2+ MM Progenitor
(A) FTLY medium preserves nuclear staining
for SIX2 and PAX2. Scale bars, 100 mm.
(B) FTLY medium significantly increases
the proportion of SIX2+ progenitors over
time/passaging in mixed rMM populations
(*p < 0.05). Error bars show variation from
three to four independent cultures.
(C) FTLY treatment significantly decreases
the proportion of PBX1+ stromal cells over
time/passaging. (*p < 0.05). Error bars
show variation from three to four indepen-
dent cultures.
(D) SIX2 expression levels decline with
rMM passaging (P) in four separate cultures
(n1–n4). E-CADHERIN is not detected.
(E) FTLY treatment preserves the expression
of progenitor markers despite multiple
(five) passages. Uncultured rMMs served as
controls.passage 5 cultures, demonstrating that SIX2+ progenitors
are preserved and persist in multi-passaged populations.
Immunoblots also showed a decline in SIX2 protein levels
from four separate cultures of rMM cells at passages 1, 3,
and 5 (Figure 2D), consistent with the loss of SIX2+ cells.
Concordant with immunostaining, ECDH was not de-
tected in later passages.
We further examined the ability of FTLY medium to
sustain the expression of several progenitor markers in
long-term cultures. RT-PCR gene expression profiles were
generated from passage 5 cells. For this, cells were briefly
trypsinized (2–3 min) and split one to three. Cells were
then passaged just prior to reaching confluence (every
4–5 days). Therefore, by passage 5, cells had been in culture
for nearly 1 month. The profile for passage 5 FTLY-treated
MMs still closely resembled that for uncultured rMMs with
retention of Six2, Eya1, Sall1, Cited1, Pax2, and Hoxa11,
whereas the differentiation markers Lim1 and E-cadherin438 Stem Cell Reports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Authorswere reduced greatly (Figure 2E). On
the other hand, FT-treated cultures
showed reduced levels of expression
of most of the progenitormarkers rela-
tive to FTLY treatment, demonstrating
a significant improvement in long-
term progenitor maintenance.
LIF/Rho Kinase Inhibitor Preserves
the Capacity of rMM Progenitors
to Respond to Inductive Signaling
To assess whether progenitors re-
tained an ability to epithelializeupon cue, rMMs grown in FT or FTLY medium for 10 days
were trypsinized and plated in FT medium without or
with WNT4 (100 ng/ml). Expression of the differentiation
markers Lim1 and E-cadherin was upregulated 3- to 4-fold
with a 72-hr WNT4 treatment (Figure 3A). Passage 5 cells
also responded to a 3-day induction with LIF (50 ng/ml)
or the GSK3b inhibitor CHIR99021 (1 mM) by upregulating
the expression of the differentiation markers Lim1 and
E-cadherin only when cells had been propagated continu-
ously in FTLYmedium (Figure 3B). To evaluate this respon-
siveness more rigorously, primary and passaged rMM
cells were assessed for their ability to form colonies on
WNT4-expressing NIH 3T3 cells. Only multipotent MM
progenitors generate colonies in this assay and exhibit
multi-lineage differentiation from a single progenitor (Osa-
fune et al., 2006). For these studies, WNT4-expressing NIH
3T3 cells that had been placed in stasis by treatment with
mitomycin C were seeded into wells (500,000 cells/well)
Figure 3. FTLY-Treated rMMs Remain
Competent to Respond to Induction and
Form Tubules
(A) WNT4 (100 ng/ml) induces the differ-
entiation markers Lim1 or E-cadherin in
FTLY-treated rMMs. Cells were treated for
72 hr and analyzed by qPCR.
(B) Passaged FTLY-treated rMM cells also
respond to inductive cues. Passage 5 cells
treated with LIF (50 ng/ml) or CHIR99021
(CHIR, 1mM) for 72 hr upregulate Lim1 and
E-cadherin, as shown by RT-PCR.
(C) Passaged FTLY-treated rMM cells form
colonies on NIH 3T3WNT4 feeder cells. Iso-
lated rMM cells served as controls.
(D) rMM cells propagated in FTLY medium
form mature renal tubules and glomerular-
like structures. rMM cells cultured and
passaged in FT or FTLY medium were H&E-
stained or probed for expression of the
nephronic markers WT1 (condensed mesen-
chyme or podocytes), NEPHRIN (podocytes/
glomeruli), CADHERIN6 (CDH6, proximal
tubules), and E-CADHERIN (ECDH, distal
tubules). Scale bars, 50 mm.of a fibronectin-coated, 12-well plate in DMEM with 10%
fetal bovine serum (FBS). The following day, 100,000
rMM cells were added per well in a colony assay medium.
Only sizable colonies (>10 cells) were counted. In this
study, no colonies were observed in co-cultures containing
100,000 rMM cells propagated in FT control medium for
10 days, whereas cells grown in FTLY medium for 10 days
sustained the ability to form colonies at a level greater
than 50% that of uncultured rMMs (Figure 3C). The fre-
quency of colony formation declined with passage, but
small numbers of WNT4-responsive colonies were consis-
tently observed even at passage 5, again demonstratingStem Cell Reports j Vol. 5 j 435–447the preservation of a competent pro-
genitor population in these cultures.
Cultured cells were also assessed for
their ability to form nephronic
epithelia and undergo segmentation.
For this, cells maintained in FT or
FTLY medium were passaged and
then co-cultured with embryonic spi-
nal cord. Initially, 100,000 rMM cells
were allowed to aggregate in wells of
a 96-well, low-binding affinity plate
for 48 hr and then transferred to filters
with embryonic spinal cord. They
were then cultured for 8 days on me-
dium with 10% FBS. Under these con-ditions, control (FT-treated) cells at first passage yielded
small, necrotic aggregates with some primitive epithelia
that were devoid of any glomerulus-like structures (Fig-
ure 3D). Some aggregates expressed WT1, a marker of
condensed mesenchyme, and the epithelia exhibited
ECDH or CDH6 staining, which label distal and proximal
tubules, respectively. However, NEPHRIN, a glomerular
marker, was never detected. This is consistent with the in-
duction of primitive epithelia by FGF2 (Karavanov et al.,
1998). By passage 2, all FT-treated cultures failed to form
even primitive epithelia or stain for any nephron markers
(Figure 3D). On the other hand, FTLY-treated and passagedj September 8, 2015 j ª2015 The Authors 439
Figure 4. LIF Activates STATs, which Regulate SIX2 Expression
(A) LIF induces phosphorylation of multiple STATs in a dose-
dependent manner. Passaged rMM cells were treated with LIF for
15 min.
(B) Stat siRNA knockdown inhibits SIX2 expression. rMM cells were
analyzed 72 hr after transfection.
(C) LIF and Y27632 enhance nuclear levels of SIX2 and pPAX2.
GAPDH marks the cytosolic fraction and LAMIN A/C the nuclear
fraction.
(D) STAT3 binds to the Six2 proximal promoter in primary mMM
cells. Top: schematic of two putative Stat response elements
(StatRE) within the 5-kb upstream proximal promoter of the
mouse Six2 locus. Center: ChIP-PCR demonstrating that the pro-
moter-established STAT3 target Socs3 is bound by STAT3 in
response to LIF. Bottom: ChIP qPCR analysis revealing binding of
STAT3 to the upstream (StatRE1) region of Six2 under LIF-stimu-
lated conditions. mMM cells were treated until confluency with FT
or FTL (LIF = 5 ng/ml) prior to fixation. IP, immunoprecipitation.cells were expanded dramatically, preserved well, and
populated with numerous tubules and glomerulus-like
structures at both passages (Figure 3D; Figures S4A and
S4B). NEPHRIN staining was demonstrable in glomerulus-
like foci, and expression of both CDHs was robust.
Therefore, FTLYmedium preserved the competence of pro-
genitors to form mature segmented nephronic epithelia.
Attempts to induce later-passage cells with embryonic spi-
nal cord, however, were unsuccessful. This likely reflects
the depletion of SIX2+ progenitors at passage 3, but, as
noted, their loss did not preclude the ability of the remain-
ing cells to respond to inductive signals.
Mouse MM Progenitors Are Also Preserved with
LIF/ROCKi Treatment
In addition to rat MM cells, comparable culture conditions
were applied to mMM cells isolated from E11.5 embryos.
Cells were expandedwith FTLYmedium and then passaged
in FT medium with or without LIF or Y27632 for 48 hr. By
IF, the majority of cells showed nuclear SIX2 staining in
LIF-treated cultures, whereas only a small fraction of cells
in FT-treated cultures had stained nuclei (Figure S5A).
Furthermore, the expression of stem cell markers after
10 days was preserved only with the addition of LIF (Fig-
ure S5B). At 1–5 ng/ml, the expression of Six2, Cited1,
and Sall1 was robust, and E-cadherin was minimized.
Furthermore, when FTLY-treated cells were exposed to the
GSK3b inhibitor CHIR99021, both Lim1 and E-cadherin
were upregulated (Figure S5C), suggesting that mMM also
remained competent to respond to induction.
LIF Activates STAT Signaling to Sustain SIX2
LIF functions primarily through the activation of a Janus
kinase to phosphorylate a STAT molecule, which then oli-
gomerizes and moves to the nucleus for transcriptional
activation (Stephens et al., 1998). Phosphorylation
occurs within minutes of LIF exposure. However, STAT
upregulates its own expression, yielding high levels of an
unphosphorylated form (U-STAT), which also binds DNA
(Timofeeva et al., 2012) to activate or repress gene tran-
scription (Yang and Stark, 2008). Multiple STAT family
members are expressed in the developing metanephros
(Wang et al., 2010), so we assessed the ability of LIF
to induce phosphorylation of those STATs. Although
1 ng/ml LIF is optimal for rMM self-renewal, we reported
that higher levels (50 ng/ml) induce MET in progenitors
(Plisov et al., 2001). Therefore, we evaluated phosphoryla-
tion at both concentrations. In rMM cells, STATs 1, 3, 4, 5,
and 6 were all expressed and could be activated by LIF.
However, LIF stimulated the phosphorylation of only
STATs 1, 3, and 5 at 1 ng/ml, suggesting that these STATs
mediate LIF signals in our progenitors (Figure 4A).
Y27632 elicited no effect on STAT phosphorylation. These440 Stem Cell Reports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Afindings confirm that LIF activates canonical STAT
signaling in cultured rMMcells and establishes redundancy
in STAT responses to LIF.
To directly assess the role of STATsignaling in themainte-
nance of the stem cell phenotype, Stats were knocked
down individually or collectively with small interfering
RNA (siRNA) in rMM cells monitored for SIX2 expression
(Figure 4B). Cells (106) were transfected using Lipofect-
amine RNAi MAX and cultured for 3 days in a fibronectin-
coated 12-well plate. Consistent with a role in stem celluthors
stabilization, knockdown (KD)of Stats 1,3, or5 individually
showed reduced levels of SIX2 expression. Furthermore,
the greatest SIX2 reduction was observed with KD of all
three Stats. The resulting partial attenuation of SIX2
may either reflect the involvement of other factors in regu-
lating its expression or possibly the loss of preferential
growth of the SIX2+ progenitor. Nuclear levels of stem cell
markers were also evaluated in cells treated with FT plus
LIF (1 ng/ml) or Y27632 after 3 days in culture. Individually,
both LIF and Y27632 treatments increased nuclear SIX2
levels (Figure 4C). Furthermore, the combination greatly
increased nuclear levels of pPAX2. FGF2 is known to acti-
vate STAT signaling (Megeney et al., 1996), so it is not sur-
prising that FT (control) medium also induced nuclear
STAT3. LIF, however, overcame the attenuating effects of
Y27632 on nuclear STAT3. These studies suggest that both
LIF and Y27632 regulate nuclear levels of SIX2 and PAX2,
but, again, this result could be explained either by growth
selection of the SIX2+ cell or by induction of expression.
Because cytosolic SIX2 was not demonstrable in immu-
noblots (Figure 4C), we hypothesized that this transcrip-
tion factor is unstable outside of the nucleus. To test this,
cells were exposed to the proteasomal inhibitor MG132
and harvested as above. Under these conditions, a promi-
nent cytosolic band of the appropriate size was detected
(Figure S6A), indicating that SIX2 is degraded rapidly in
the cytoplasm and suggesting that any cytoplasmic IF
staining for SIX2 is attributable to its degradation products.
To better understand a possible relationship between
STAT activation and Six2 expression, we examined direct
binding of STAT3 to the Six2 promoter using a chromatin
immunoprecipitation (ChIP) assay. Because the mouse
genomehas beenmuchmore rigorously sequenced and an-
notated in the Six2 promoter than the rat genome, mMM
cells were used for ChIP analysis. Isolated mMM cells
were propagated in FT or FTL (5 ng/ml LIF) medium to
confluence (6–8 days). In silico analysis of the Six2 prox-
imal promoter revealed two clearly defined Stat consensus
binding sites (StatRE1 and StatRE2) within 5 kb of the start
codon (Figure 4D, top). Socs3 is a well established direct
target for STAT3 binding and was included as a positive
control (Figure 4D, center). LIF treatment significantly
increased STAT3 binding to the Socs3 promoter, demon-
strating the efficacy of the procedure. Similarly, STAT3
binding to the Six2 promoter was enhanced with LIF treat-
ment, exhibiting a nearly 6-fold enrichment in recruitment
to the Six2 StatRE1 relative to StatRE2 (Figure 4D, bottom).
Therefore, STAT3 binds directly to the Six2 promoter. Given
that binding is plotted relative to an internal control, a
lower-affinity StatRE2 site, the 6-fold differential between
StatRE1 and StatRE2 is likely due to a bona fide increase
in binding rather thanmerely a selection for the SIX2+ pro-
genitor, although we cannot rule out the latter.Stem CellLIF Differentially Activates PLCg to Suppress SIX2
Expression
As mentioned above, LIF mediates opposing concentra-
tion-dependent activities in rMM cells. To better under-
stand the basis for this, we evaluated the ability of LIF
to activate CALCINEURIN/calcium signaling as described
previously for Wnt4 (Tanigawa et al., 2011). When
cultured rMMs were induced with 50 ng/ml LIF, both
differentiation markers, Lim1 and E-cadherin, were upregu-
lated after 6 days of treatment (Figure 5A). However, cyclo-
sporine A (CsA), a CALCINEURIN/NFAT inhibitor, blocked
the ability of LIF to induce the expression of these markers,
whereas the b-CATENIN inhibitor CT-HC-1 had no effect
on differentiation. Therefore, both LIF andWNT4 mediate
MET through a calcium-dependent mechanism. Because
the PHOSPHOLIPASE C (PLC) metabolite inositol 1,4,5-tri-
sphosphate stimulates calcium release and uptake and
because JAK/STAT signaling can also initiate a calcium
cascade through PLC activation (Soriano et al., 2003), we
evaluated PLC phosphorylation following treatment of
rMMs with 1 or 50 ng/ml LIF. As shown in Figure 5B,
1 ng/ml LIF induced a small, brief elevation of PLCg1
phosphorylation for a 5- to 10-min time period, whereas
50 ng/ml LIF caused a robust increase in phosphorylation
for at least 60 min. Simultaneously, pSTAT3 and 5 re-
mained greatly elevated at both LIF concentrations, sug-
gesting that a differential in PLCg1 phosphorylation may
contribute to the concentration-dependent responses
and that this balance may help determine when the
progenitor commits or self-renews. Conversely, knock-
down of PLCg1 over 72 hr caused an increase in SIX2
levels in immunoblots of FTLY-cultured rMMs (Figure 5C),
suggesting that it may play a regulatory role in lineage
commitment.
Y27632 Attenuates JNK Signaling and Activates Slug
Expression when Combined with LIF
JNK inhibitors block expression of differentiation markers,
including E-cadherin, in mMMs (Osafune et al., 2006). In
rMM cells, 1 ng/ml LIF weakly activated the 46-kDa form
of pJNK, whereas 50 ng/ml greatly elevated phosphoryla-
tion of both the 46- and 55-kDa pJNK isoforms after
only 15 min of treatment (Figure 5D). Moreover, the JNK
inhibitor SP600125 abrogated the expression of Lim1 and
E-cadherin in rMM cells treated for 6 days (Figure 5E). The
EMT regulatory factor Slug/Snai2, which is expressed in
MM progenitors (Savagner et al., 1998), was also evaluated
in response to LIF treatment. LIF (50 ng/ml) inhibited Slug
expression in rMMs treated for 6 days (Figures 5F and 5G)
unless partnered with a JNK inhibitor with which it
stimulated Slug levels instead (Figure 5G). These findings
provide strong evidence that LIF plays a dual role in cells.
Through STAT signaling, it supports stemness by selectingReports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Authors 441
Figure 5. LIF Activates PLCg and JNK in a
Dose-Dependent Manner
(A) Calcium/NFAT signaling mediates LIF-
induced MET. rMMs were treated with LIF
(50 ng/ml) in the presence of the calcium/
NFAT inhibitor CsA (10 mM) or the b-CAT-
ENIN inhibitor CT-HC-1 (10 mM) for 6 days
and analyzed for the MET markers Lim1 and
E-cadherin.
(B) LIF differentially activates PLCg.
Passaged rMM cells were treated with 1 or
50 ng/ml LIF.
(C) PLCg negatively regulates SIX2 and YAP
expression. rMM cells transfected with Plcg
siRNA were harvested after 72 hr.
(D) Y27632 attenuates LIF-induced JNK
phosphorylation. Cells were pretreated with
Y27632 (10 mM) for 30 min and then with
LIF for 15 min.
(E) JNK facilitates LIF-induced MET in rMMs.
rMMs were treated with LIF (50 ng/ml) or
the JNK inhibitor SP600125 (10mM) for
6 days.
(F) LIF suppressed Slug/Snai2 expression
during MET. rMMs were treated with LIF
(50 ng/ml) for 6 days.
(G) SP600125 reverses the LIF-induced
suppression of Slug in rMM cells. rMMs were
treated with LIF (50 ng/ml) or SP600125
(10mM) for 6 days.
(H) LIF (1 ng/ml) plus Y27632 stimulates
Slug expression in cultured rMM cells.SIX2+ cells or inducing SIX2 expression while also acti-
vating PLC and JNK to facilitate MET.
Rho kinase regulates JNK signaling by activating/phos-
phorylating JNK itself (Marinissen et al., 2004). As pre-
dicted, Y27632 attenuates JNK phosphorylation of both
the 46- and 55-kD isoforms (Figure 5D). Interestingly, LIF
with Y27632 also stimulated Slug expression in rMMs
treated for 6 days (Figure 5H), as observed with the JNK in-
hibitor (Figure 5G). These findings suggest that Y27632
helps maintain rMMs by inhibiting their differentiation
through attenuation of JNK activity.
LIF Induces YAP, which Regulates Several rMM
Stemness Markers
YAP is involved in the regulation of MM progenitors both
in vivo and in short-term primary culture (Das et al.,
2013). In those studies, it was predominantly nuclear local-
ized in cultured cells at low density but lost from nuclei in
rMM cells cultured for 72 hr at high density (arrows), as
shown in Figure 6A. In contrast, FTLY-treated rMM progen-
itors showed nuclear YAP in cells regardless of density, sug-442 Stem Cell Reports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Agesting that FTLY overcomes any density-dependent
repression of YAP signaling. To further investigate this phe-
nomenon, rMM progenitors were cultured in FT medium
with LIF or Y27632 for 72 hr and evaluated for YAP or
TAZ (Figure 6B). Although cytosolic levels of YAP/TAZ
were similar regardless of treatment, 1 ng/ml LIF greatly
increased the nuclear levels of both. Interestingly, Y27632
abrogated this response, but the effect could then be
rescued with LIF. These studies suggest that LIF may acti-
vate YAP signaling in rMM cells and demonstrate that LIF
and Y27632 play distinct but complementary roles in
maintaining the MM progenitor.
To determine whether YAP also stabilizes stem marker
expression in rMM progenitors, FTLY-treated cells were
transfected with Yap siRNA and cultured for 72 hr. This re-
sulted in a substantial loss of YAP and the downregulation
of expression of all stem markers, including SIX2, CITED1,
PAX2, and SALL1 (Figure 6C), suggesting that it plays a ma-
jor role in the regulation of key stem cell regulatory factors.
Yap knockdown also caused a concomitant increase in the
expression of the differentiation markers Pax8, E-cadherin,uthors
Figure 6. YAP Regulates Progenitor Markers
(A) LIF and Y27632 override density-dependent signals for nuclear
localization of YAP. White arrows indicate dense areas lacking Yap
nuclear localization. Scale bars, 100 mm.
(B) LIF increases nuclear levels of YAP/TAZ. Cells were cultured
for 72 hr (LIF, 1 ng/ml). GAPDH and LAMIN A/C distinguished
fractions.
(C) Yap knockdown decreased progenitor marker expression in
rMM cells.
(D) Silencing Yap increased the expression of differentiation
markers in rMM cells.
(E) Tead knockdown upregulated differentiation markers in
rMM cells.and Lim1 (Figure 6D). Conversely, knockdown of PLCg not
only upregulated SIX2 expression, as described earlier, but
also upregulated YAP expression (Figure 5C). This suggests
that YAP and calcium signaling function in tandem to bal-
ance MM progenitor commitment to nephronic differenti-
ation and that loss of nuclear YAP is sufficient to permit
MET.
YAP Functions in MM Progenitors by a
TEAD-Dependent Mechanism
To directly determine whether the canonical YAP transcrip-
tional partner TEADmediates YAP activity in rMMs, all fourStem CellTEAD family members were knocked down collectively in
cells, which were then analyzed for the induction of the
differentiation markers E-cadherin and Pax8. Expression
levels for each individual TEAD were depressed signifi-
cantly following knockdown (Figure S6B) and resulted in
an upregulation of both Pax8 and E-cadherin (Figure 6E).
Therefore, YAP likely functions through TEAD activation
to suppress the differentiation of rMM progenitors.DISCUSSION
In this study, we define serum-free culture conditions that
permit the massive, rapid, and preferential expansion of
SIX2+ MM progenitors with the preservation of a stem-
like phenotype. Furthermore, the cells derived from
these conditions retain their capacity to form nephronic
tubules and glomeruli when induced with embryonic spi-
nal cord and remain responsive to inductive signals
after multiple passages. This is the first evidence showing
that functional nephronic progenitors can be maintained
in culture long-term. We also demonstrate the efficacy of
genetically manipulating these cells and interrogating
specific signaling mechanisms through gene-targeted
knockdowns.
Previously we reported the propagation of rMM progen-
itors with FT medium and short-term retention of func-
tionality (Tanigawa et al., 2011), but, here, we demonstrate
that cells lose Six2 and Pax2 expression in primary culture
and become unresponsive to inductive signals. SIX2+/
PAX2 mMMs were passaged successfully as nephro-
spheres, but the cells failed to epithelialize at any passage
(Lusis et al., 2010). PAX2 facilitates competency in mMM
progenitors, allowing them to undergo MET (Brophy
et al., 2001), and is likely required for the long-term induc-
ibility of these cells. As shown here, the combination of
LIF and Y27632 sustained Pax2 expression in rMMs and
stimulated nuclear levels of pPAX2. Therefore, both SIX2
and PAX2 may be functional determinants for the success-
ful culture of nephronic stem cells.
FTLY preferentially expanded the SIX2+ population in
ourmixedMMcultures. The exact basis for this is unknown
butmay be due to the elaboration of the LIF receptor on cap
mesenchyme cells (Plisov et al., 2001). In embryonic rat
kidney, LIFR antibody labeled the membranes of cap cells,
whereas membrane staining of the interstitial stroma was
not apparent. By whatever mechanism, the selectivity
complicates our findings because many of our experiments
were performed over a 7- to 10-day period, during which
selection had occurred. Regardless, the use of an internal
low-affinity binding site as the control should have
partiallymitigated any selectivity in our ChIP experiments.
Moreover, the combination of STAT redundancy, partialReports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Authors 443
Figure 7. Model of MM Induction (A) or Stem Cell Stabilization
(B) Based on Our Findings with LIF and Y27632.retention of SIX2, and 3-day time points should have pre-
cluded the selective loss of SIX2+ cells in the Stat knock-
down studies. Still, further study of the direct role of LIF
on Six2 expression in these cells is clearly warranted.
We demonstrate that LIF affects signaling inMMprogen-
itors in a concentration-dependent manner (Figure 7; Fig-
ure S7). At 1 ng/ml, it induces phosphorylation primarily
of STATs 1, 3, and 5 as well as the expression of several
progenitor markers, whereas, at 50 ng/ml, it additionally
activates both PLCg and JNK. Because the higher concen-
tration of LIF is associated with the induction of MET and
nephronic tubule formation (Barasch et al., 1999; Plisov
et al., 2001), it is possible that PLCg and JNK are involved
in those morphogenetic processes. The PLCg metabolite
IP3 activates PROTEIN KINASE C, which initiates an intra-
cellular calcium cascade. Because knockdown of PLCg up-
regulated the expression of the stem markers SIX2 and
YAP, it is likely that LIF-activated PLCg helps override the
stemness program to direct cells to form tubules. This is
supported by the fact that PLCg-deficient chimeric mice
develop cystic kidneys, a symptom of aberrant tubular pro-
liferation (Shirane et al., 2001).
In this study, LIF also induced JNK phosphorylation and
upregulated the expression of the differentiation markers
Lim1 and E-cadherin. This induction was attenuated by
treatment with a JNK inhibitor. Furthermore, both the
JNK and ROCK inhibitors facilitated expression of the
progenitor marker Slug but, interestingly, only in concert
with LIF. These findings suggest that the role of Y27632
may be to limit the LIF-induced, JNK-mediated differentia-
tion of rMMs and, instead, help sustain cells in a more
primitive state.
Yap plays a major role in maintaining the pluripotency
of mouse ESCs (mESCs), and LIF is in part responsible for444 Stem Cell Reports j Vol. 5 j 435–447 j September 8, 2015 j ª2015 The Asustaining YAP expression in those cells (Tamm et al.,
2011). In turn, YAP stimulates LIF receptor expression,
facilitating mESC competency to respond to LIF. Further-
more, YAP complexes with a TEAD family member to acti-
vate transcription of LIF-dependent targets in mESCs. We
provide the first evidence showing that LIF functions simi-
larly in MMs by increasing nuclear levels of YAP and sus-
taining the expression of several MM stemness markers.
We also found that YAP signals inMMs through a canonical
mechanism involving TEAD transcriptional activation, as
observed for mESCs. Tead-2/4 are both expressed in MMs
(GUDMAP, Andrew P. McMahon lab) and are therefore
the most likely to co-localize with YAP/TAZ (Das et al.,
2013). Moreover, FTLY stimulated proliferation ofMMpro-
genitors and permitted nuclear localization of YAP even in
areas of high density. This suggests that the combined
treatment of LIF and Y27632 onMMcells constitutively ac-
tivates YAP and may explain not only the dramatic growth
observed in treated cultures but also the retention of a
stem-like phenotype of the progenitors in long-term
cultures.
Although our studies bring new attention to the role of
LIF/JAK/STAT signaling in regulating stemness of the MM
progenitor, we have yet to address how this may interface
with the established role of b-CATENIN in this process.
Mouse genetic studies have clearly implicated canonical
WNT signaling in the maintenance of the MM progenitor
(Karner et al., 2011; Park et al., 2007). Because a combina-
tion of LIF and aWNT is sufficient to support the expansion
of germline-competent mouse ESCs (ten Berge et al., 2011),
it is intriguing that bothmay also be necessary for the long-
term propagation of MM progenitors. As indicated, our
current conditions do not preserve the capacity of cells to
form tubules over several passages. This is likely due to
the depletion of progenitors that commit spontaneously
to primitive epithelia. Perhaps a deficiency in canonical
WNT signaling is responsible, a possibility currently under
investigation.EXPERIMENTAL PROCEDURES
Tissues and Primary MM Cell Cultures
Metanephric mesenchymes were enzymatically separated from
T-shaped ureteric buds of E13.5 rat or E11.5 mouse embryos as
described previously (Perantoni et al., 1991) and cultured as
described by Tanigawa et al. (2011). Cells were dissociated with
0.25% trypsin-EDTA solution (Gibco-Invitrogen) and washed
with PBS for passaging.Cell Proliferation Assay
Primary cultures of rMM cells were trypsinized, and cells (1–9 3
104 cells/well) were plated in a 96-well plate and treated as indi-
cated for 72 hr. Cell viability and growth were assessed usinguthors
WST-1 cell proliferation reagent (Roche Applied Science) according
to manufacturer’s instructions.
Population Analysis
Cells were seeded in four-chamber fibronectin-coated slides at
50,000 cells/chamber, fixed after 24 hr (unless expanded as pri-
maries for 7 days), and probed for SIX2 (nephronic progenitors)
or PBX1 (stroma). Counts of cells with stained nuclei were
compiled from an analysis of 500–2,000 cells/slide using a Zeiss
LSM710 confocal microscope. All points were generated from
three independent cultures.
Colony Assay
Colony formation by MM progenitors was performed as described
previously (Osafune et al., 2006) with minor modifications. A
clone of WNT4-expressing NIH 3T3 cells (Andreas Kispert) was
selected for high WNT4 expression (Jeffrey Rubin) and used as a
feeder layer for these studies. Mitomycin C-treated feeder cells
were seeded in 12-well dishes (500,000 cells/well) in DMEM with
10% FBS. The following day, themediumwas replacedwith colony
assay medium, and MM cells (100,000/well) were added. Colony
formation was assessed after 7 days.
Animals
All animal procedures were performed following guidelines from
the National Cancer Institute (NCI)-Frederick Animal Care and
Use Committee. NCI-Frederick is accredited by the Association
for Assessment and Accreditation of Laboratory Animal Care
International and follows the Public Health Service Policy for the
Care and Use of Laboratory Animals. Animal care was provided
in accordance with the procedures outlined in the Guide for Care
and Use of Laboratory Animals (National Research Council,
1996, National Academy Press, Washington, D.C.).
Semiquantitative RT-PCR
Analyses were performed as described previously (Tanigawa et al.,
2011). Primer sequences, annealing temperatures, and cycle pa-
rameters are shown in Table S1.
Immunoblotting
Immunoblottingwas performed as described previously (Tanigawa
et al., 2011).
Cell Fractionation
Nuclear and cytosolic proteins were prepared according to Dignam
et al. (1983). Briefly, cells were treated for 72 hr, harvested in cold
PBS, and pelleted (500 3 g) for 5 min. Pellets were lysed with
buffer A (10 mM HEPES-KOH [pH 7.9], 10 mM KCl, 0.1 mM
EDTA, 0.5% Nonidet P-40, 1 mM dithiothreitol, and 0.5 mM
phenylmethylsulfonyl fluoride [PMSF]) on ice for 20 min and
centrifuged (14,000 3 g) for 15 min at 4C. Supernatants served
as cytoplasmic fractions. Nuclear pellets were washed three
times with buffer A and resuspended in buffer B (20 mM HEPES,
0.5 M KCl, 1 mM EDTA, 1 mM dithiothreitol, and 1 mM PMSF
[pH 7.9]) for 30 min at 4C on a rotating wheel and centrifuged
at 14,000 3 g for 15 min at 4C. One part of the cytosolic andStem Cellnuclear fractions was analyzed using anti-LAMIN A/C or anti-
GAPDH antibody. Protein concentration was determined using a
protein assay kit (Bio-Rad) according to the manufacturer’s
instructions.
Plasmids and Electroporation
Transfections were performed as described previously (Tanigawa
et al., 2011), except with 2 mg plasmid and 5 3 105 cells/transfec-
tion. After 24 hr, cells were harvested with TRIzol reagent (Invitro-
gen) for RNA isolation. Transfection efficiencies were greater
than 90%.
siRNA Transfection
siRNA reagents were transfected into rat MM cells by Lipofect-
amine RNAi MAX (Invitrogen) reagent using the manufacturer’s
protocol. The culture medium was changed 24 hr after transfec-
tion, and transfection efficiency was analyzed by qRT-PCR or
immunoblotting.
Immunocytochemistry/Immunofluorescence
Primary MM cells were cultured on four chamber matrix-coated
slides.Cellswerefixed(4%paraformaldehyde/10min)andprocessed
according to Abcam’s immunocytochemistry protocol (http://www.
abcam.com/index.html?pageconfig=popular_protocols), blocking
with 10% goat serum and mounting in Vectashield (Vector Labora-
tories). Cells were visualized on an LSM710 confocal microscope
(Carl Zeiss) and analyzed by ZEN image software (Zeiss). IF staining
for nephron segment-specific markers was performed as described
previously (Taguchi et al., 2014).
Chromatin Immunoprecipitation Assay
The 5-kb upstreampromoter regionofmouse Six2was interrogated
for known transcription factor binding elements using the web-
based TFSearch program (http://diyhpl.us/bryan/irc/protocol-
online/protocol-cache/TFSEARCH.html). ‘‘Statx’’ sites with a score
of R90 were probed for STAT3 binding by ChIP. Primary mMM
cells were cultured as described previously in FT medium with or
without LIF (5 ng/ml) for 6–8 days in 60-mm dishes. ChIP was
done as described previously (Lee et al., 2006). Briefly, cells were
fixed (1% paraformaldehyde/15 min) and sonicated (60 min) on
ice using a Bioruptor at low power and a 30-s on/off oscillation pro-
gram (average fragmentation of 500–1,000 bp). Recruitment of
STAT3 to target DNA elements was evaluated by PCR or qPCR
following immunoprecipitation of STAT3 (Cell Signaling Technol-
ogy, antibody 9139S). Primers are shown in Table S1.
Statistical Analysis
Data were evaluated as described previously using Student’s t test
(Tanigawa et al., 2011). All experiments were performed indepen-
dently at least three times. Error bars represent the variation
from three or more independent experiments.
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